NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Haemonetics Corporation provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software. It also provides automated blood component and manual whole blood collection systems.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $870.5M | $993.2M | $1.2B | $1.3B | $1.4B | $1.3B |
| Gross profit | $397.8M | $505.5M | $615.1M | $691.5M | $749.0M | $787.6M |
| Operating income | $89.7M | $80.8M | $156.0M | $164.9M | $221.8M | $156.7M |
| Net income | $79.5M | $43.4M | $115.4M | $117.6M | $167,679.00 | $97,308.00 |
| Diluted EPS | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 | $2.05 |
| Operating cash flow | $108.8M | $172.3M | $273.1M | $181.8M | $181.7M | $293.2M |
| Free cash flow | $71.8M | $75.8M | $81.7M | $143.6M | $142.4M | $260.4M |
| Gross margin | 45.7% | 50.9% | 52.6% | 52.8% | 55.0% | 59.0% |
| Operating margin | 10.3% | 8.1% | 13.4% | 12.6% | 16.3% | 11.7% |
| Net margin | 9.1% | 4.4% | 9.9% | 9.0% | 0.0% | 0.0% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $336.2M | $345.5M | $348.5M | $330.6M | $321.4M | $327.3M | $339.0M | $346.4M |
| Gross profit | $174.9M | $187.4M | $193.5M | $193.1M | $192.2M | $194.7M | $202.4M | $198.2M |
| Operating income | $39.8M | $51.7M | $59.0M | $71.3M | $53.9M | $58.5M | $67.4M | -$23.0M |
| Net income | $38.4M | $33.8M | $37.5M | -$109.5M | $34.0M | $38.7M | $44.7M | -$117.4M |
| Diluted EPS | $0.74 | $0.66 | $0.74 | $1.17 | $0.70 | $0.81 | $0.95 | -$0.41 |
| Operating cash flow | -$27.4M | $48.8M | $43.8M | $116.6M | $17.4M | $111.3M | $93.6M | $70.9M |
| Free cash flow | -$33.1M | $39.4M | $35.2M | $100.9M | $13.6M | $106.3M | $87.2M | $53.3M |
| Gross margin | 52.0% | 54.2% | 55.5% | 58.4% | 59.8% | 59.5% | 59.7% | 57.2% |
| Operating margin | 11.8% | 15.0% | 16.9% | 21.6% | 16.8% | 17.9% | 19.9% | -6.6% |
| Net margin | 11.4% | 9.8% | 10.8% | -33.1% | 10.6% | 11.8% | 13.2% | -33.9% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-05 | Miller Laurie A.· SVP, Human Resources | Tax withholding | 313 | $71.28 | $22,310.64 | filing |
| 2026-06-05 | Maunsell Farris Maryanne· VP, Chief Accounting Officer | Tax withholding | 259 | $71.28 | $18,461.52 | filing |
| 2026-05-15 | Simon, Christopher· President & CEO | Tax withholding | 9,681 | $56.29 | $544,943.49 | filing |
| 2026-05-15 | Basil Michelle L· EVP and General Counsel | Tax withholding | 2,913 | $56.29 | $163,972.77 | filing |
| 2026-05-15 | DArecca James· EVP, Chief Financial Officer | Tax withholding | 2,505 | $56.29 | $141,006.45 | filing |
| 2026-05-15 | Miller Laurie A.· SVP, Human Resources | Tax withholding | 948 | $56.29 | $53,362.92 | filing |
| 2026-05-15 | Galvin Roy· EVP, Chief Commercial Officer | Tax withholding | 879 | $56.29 | $49,478.91 | filing |
| 2026-05-15 | Chan Frank· EVP, Chief Operating Officer | Tax withholding | 546 | $56.29 | $30,734.34 | filing |
| 2026-05-15 | Maunsell Farris Maryanne· VP, Chief Accounting Officer | Tax withholding | 197 | $56.29 | $11,089.13 | filing |
| 2026-05-15 | Simon, Christopher· President & CEO | Award | 78,344 | — | — | filing |
| 2026-05-15 | Basil Michelle L· EVP and General Counsel | Award | 28,424 | — | — | filing |
| 2026-05-15 | Chan Frank· EVP, Chief Operating Officer | Award | 27,535 | — | — | filing |
| 2026-05-15 | DArecca James· EVP, Chief Financial Officer | Award | 29,312 | — | — | filing |
| 2026-05-15 | Maunsell Farris Maryanne· VP, Chief Accounting Officer | Award | 2,220 | — | — | filing |
| 2026-05-15 | Galvin Roy· EVP, Chief Commercial Officer | Award | 27,535 | — | — | filing |
| 2026-05-15 | Miller Laurie A.· SVP, Human Resources | Award | 13,323 | — | — | filing |
| 2026-05-01 | DArecca James· EVP, Chief Financial Officer | Tax withholding | 655 | $59.26 | $38,815.30 | filing |
| 2025-11-10 | KROLL MARK W | Buy | 1,400 | $70.56 | $98,784.00 | filing |
| 2025-10-31 | Galvin Roy· EVP, Chief Commercial Officer | Tax withholding | 145 | $50.01 | $7,251.45 | filing |
| 2025-09-17 | Miller Laurie A.· SVP, Human Resources | Tax withholding | 238 | $49.95 | $11,888.10 | filing |
| 2025-07-24 | Zane Ellen M | Award | 2,693 | — | — | filing |
| 2025-07-24 | Pomeroy Claire | Award | 2,693 | — | — | filing |
| 2025-07-24 | KROLL MARK W | Award | 2,693 | — | — | filing |
| 2025-07-24 | Johnson Lloyd Emerson | Award | 2,693 | — | — | filing |
| 2025-07-24 | Dockendorff Charles J | Award | 2,693 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.